We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
ITT
ITT
$19.4B
| $8.23M | 0.01% |
+47,461
| New | +$8.5M |
|
1077
Johnson & Johnson
JNJ
$626B
| $8.23M | 0.01% |
39,780
-151,667
| -79% | -$30M |
|
1078
CALL
Intuitive Surgical
ISRG
$142B
| $8.21M | 0.01% |
14,500
+7,500
| +107% | +$3.99M |
|
1079
Jazz Pharmaceuticals
JAZZ
$16.1B
| $8.18M | 0.01% |
48,108
-385,031
| -89% | -$59M |
|
1080
Sigma Lithium
SGML
$1.33B
| $8.17M | 0.01% |
619,669
+236,942
| +62% | +$2.04M |
|
1081
PUT
Alcoa
AA
$14.3B
| $8.15M | 0.01% |
153,400
-104,800
| -41% | -$4.29M |
|
1082
SharkNinja
SN
$26.4B
| $8.11M | 0.01% |
+72,479
| New | +$7.14M |
|
1083
WillScot Mobile Mini Holdings
WSC
$4.15B
| $8.1M | 0.01% |
430,365
+244,499
| +132% | +$4.93M |
|
|
BETA
1084
Beta Technologies Inc
BETA
$5.67B
| $8.1M | 0.01% |
+287,241
| New | +$8.57M |
|
1085
Viavi Solutions
VIAV
$9.47B
| $8.1M | 0.01% |
454,286
-718,388
| -61% | -$11.6M |
|
1086
CALL
Walmart Inc
WMT
$901B
| $8.07M | 0.01% |
72,400
+40,500
| +127% | +$4.35M |
|
1087
Kinsale Capital Group
KNSL
$8.53B
| $8.06M | 0.01% |
+20,614
| New | +$8.41M |
|
1088
RB Global
RBA
$16.6B
| $8.06M | 0.01% |
78,354
-20,258
| -21% | -$2.06M |
|
|
STLN
1089
CALL
Starling Oncology, Inc. Common Stock
STLN
$632M
| $8.06M | 0.01% |
+2,263,100
| New | +$8.39M |
|
|
EFOR
1090
Everforth Inc
EFOR
$1.35B
| $8.05M | 0.01% |
167,169
-79,990
| -32% | -$3.69M |
|
1091
PUT
Boston Scientific
BSX
$74.2B
| $8.03M | 0.01% |
84,200
+44,000
| +109% | +$4.31M |
|
1092
Crocs
CROX
$6.31B
| $8.03M | 0.01% |
93,856
-106,704
| -53% | -$8.92M |
|
1093
GATX Corp
GATX
$6.27B
| $8.02M | 0.01% |
47,305
-38,833
| -45% | -$6.4M |
|
1094
John Wiley & Sons Class A
WLY
$2.52B
| $8.01M | 0.01% |
+261,636
| New | +$9.22M |
|
1095
PUT
AB InBev
BUD
$159B
| $8.01M | 0.01% |
125,000
+50,000
| +67% | +$3.1M |
|
1096
CALL
Goldman Sachs
GS
$301B
| $8M | 0.01% |
9,100
+2,400
| +36% | +$1.96M |
|
1097
Avalo Therapeutics
AVTX
$1.04B
| $7.98M | 0.01% |
439,312
-378,124
| -46% | -$6.38M |
|
1098
Arista Networks
ANET
$250B
| $7.97M | 0.01% |
+60,844
| New | +$8.38M |
|
1099
Pampa Energía
PAM
$4.28B
| $7.95M | 0.01% |
89,856
-84,222
| -48% | -$6.79M |
|
1100
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
| $7.94M | 0.01% |
175,000
| – | – |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.